eXoZymes Inc. Common Stock EXOZ Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -185.8%— | -132.6%— | —— | —— | —— | |
| Return on assets | -124.4%— | -96.4%-25.7pp | -147.9%— | —— | —— | |
| Return on invested capital | -679.1%— | -520.5%-155pp | —— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 1.3×-5.2× | 2.5×-5.6× | 4.5×+4.3× | 6.2×— | 6.5×— | |
| Quick ratio | 1.3×-5.2× | 2.5×-5.6× | 4.5×+4.3× | 6.2×— | 6.5×— | |
| Cash ratio | 0.9×-5.0× | 1.9×-5.4× | 4.1×+4.1× | 5.7×— | 5.9×— | |
| Leverage | ||||||
| Debt-to-equity | 0.8×+0.6× | 0.4×+0.2× | 0.3×— | 0.2×— | 0.1×— | |
| Debt-to-assets | 0.3×+0.2× | 0.2×+0.1× | 0.2×-0.2× | 0.1×— | 0.1×— | |
| Interest coverage | -36.1×+25.1× | -26.8×+49.6× | -38.6×+27.5× | -37×— | -61.2×— | |
| Per Share | ||||||
| Book value per share | $0.18-83.0% | $0.41-74.5% | $0.64+211% | $0.86+339% | $1.06+631% | |
| Valuation | ||||||
| Market capitalization | $76.8M-5.6% | $91.42M— | $121.01M— | $86.36M— | —— | |
| Enterprise value | $76.57M+1.0% | $89.67M— | $117.27M— | $80.81M— | —— | |
| Price / book | 50.3×+39.0× | 26.9×— | 22.5×— | 11.9×— | —— | |
| Free cash flow yield | -9.2%+2.1pp | -7.3%— | -8.7%— | -10.7%— | —— | |
| Earnings yield | -12.6%-3.1pp | -10%— | -6.9%— | -8.9%— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do eXoZymes Inc. Common Stock's ratios come from?
- Every ratio is computed from eXoZymes Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
